Larimar Therapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D Expenses | 25.0M | 59.4M | 44.9M | 23.4M | 26.6M | 26.7M | 13.9M | 19.7M |
| Operating Expenses | 31.1M | 64.0M | 49.5M | 27.8M | 31.2M | 31.3M | 18.3M | 24.6M |
| Operating Income | -31.1M | -64.0M | -49.5M | -27.8M | -31.2M | -31.3M | -18.3M | -24.6M |
| Other Income / Gains | 1.5M | 1.5M | 1.8M | 1.6M | 1.9M | 2.5M | 2.8M | 3.0M |
| Net Income | -29.6M | -62.5M | -47.7M | -26.2M | -29.3M | -28.8M | -15.5M | -21.6M |
| EPS (Diluted) | -0.35 | -0.73 | -0.61 | -0.41 | -0.46 | -0.45 | -0.24 | -0.34 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General And Administrative Expenses | 6.1M | 4.6M | 4.6M | 4.4M | 4.6M | 4.6M | 4.3M | 4.9M |
| Selling And Marketing Expenses | 0 | 0 | 100K | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 6.1M | 4.6M | 4.7M | 4.4M | 4.6M | 4.6M | 4.3M | 4.9M |
| Other Expenses | 0 | 0 | -100K | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 31.1M | 64.0M | 49.5M | 27.8M | 31.2M | 31.3M | 18.3M | 24.6M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 64K | 87K | 88K | 87K | 88K | 77K | 74K | 87K |
| Ebitda | -29.5M | -62.4M | -47.6M | -26.1M | -29.2M | -28.7M | -15.4M | -21.5M |
| Ebitdaratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | -29.6M | -62.5M | -47.7M | -26.2M | -29.3M | -28.8M | -15.5M | -21.6M |
| Income Before Tax Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Epsdiluted | -0.35 | -0.73 | -0.61 | -0.41 | -0.46 | -0.45 | -0.24 | -0.34 |
| Weighted Average Shs Out | 85.2M | 85.2M | 78.3M | 64.0M | 64.0M | 63.8M | 63.8M | 63.8M |
| Weighted Average Shs Out Dil | 85.2M | 85.2M | 78.3M | 64.0M | 64.0M | 63.8M | 63.8M | 63.8M |